Category Ranking
98%
Total Visits
921
Avg Visit Duration
2 minutes
Citations
20
Article Abstract
Background/purpose: The maxillary sinus floor augmentation (MSFA) technique is frequently used for the preparation of implant sites in the maxillary region. The aim of this study was to investigate the 10-year outcome of dental implants placed in a grafted maxillary sinus, and identify possible risk factors for implant failure.
Materials And Methods: We retrospectively analyzed 202 implants after MSFA in 97 patients from January 2008 to April 2009. The outcome variables were 1) 10-year cumulative survival rate of the implant, 2) risk factors for implant failure, and 3) correlation between preoperative residual bone height (RBH) and graft materials in terms of implant survival. Graft materials used were divided into five different groups: autogenic, allogenic, xenogenic, combination of allogenic and xenogenic, or combination of autogenic and xenogenic graft.
Results: The cumulative 10-year survival rate for the implants was 96.04%. In regions with a residual bone height of 5.0 mm and less, greater RBH was preferable for long-term implant survival (odds ratio = 3.475; p = 0.035). Implant survival was not significantly different with different graft materials, even when RBH was unfavorable.
Conclusion: The placement of dental implants with MSFA is a reliable procedure. Further, RBH is an important predictor of long-term implant survival.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7486508 | PMC |
| http://dx.doi.org/10.1016/j.jds.2020.05.014 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Material effects on the long-term survival and complication rate of cemented implant-supported single crowns: A retrospective clinical study.
J Prosthet Dent
September 2025
Full Professor and Department Head, Department of Prosthodontics, University of Heidelberg, Heidelberg, Germany.
Statement Of Problem: Despite high survival rates of implant-supported single crowns, retention loss remains common and decementation of crowns can compromise long-term stability, patient satisfaction, and treatment costs. Limited long-term evidence on cement type, abutment design, and materials requires further research to optimize clinical outcomes.
Purpose: The aim of this retrospective clinical study was to analyze the survival and decementation rates of zirconia and metal-ceramic implant-supported crowns in combination with different abutments (prefabricated or custom and unabraded or airborne-particle abraded).
Orthotopic model of tongue cancer for the study of head and neck squamous cell carcinoma in mice.
Methods Cell Biol
September 2025
Centre de Recherche des Cordeliers, Equipe Labellisée par la Ligue Contre le Cancer, Université de Paris Cité, Sorbonne Université, Inserm U1138, Institut Universitaire de France, Paris, France; Metabolomics and Cell Biology Platforms, UMS AMICCa, Gustave Roussy, Villejuif, France; Department of
Head and neck squamous cell carcinoma (HNSCC) is among the most prevalent human malignancies globally, with approximately 887,000 new cases diagnosed each year. Currently, the standard treatment for HNSCC involves surgery, followed by radiotherapy, chemotherapy and immunotherapy. However, despite these available treatments, the survival rate of patients with HNSCC remains low.
View Article and Find Full Text PDF5-Year Outcomes With a Novel Coronary Sirolimus-Eluting Bioresorbable Scaffold: The NeoVas Randomized Trial.
JACC Cardiovasc Interv
September 2025
The Zena and Michael A. Wiener Cardiovascular Institute, Icahn School of Medicine at Mount Sinai, New York, New York, USA.
Background: Previous trials have demonstrated increased 5-year risks for adverse clinical events after coronary artery implantation of poly-l-lactic acid-based bioresorbable scaffolds (BRS) compared with cobalt chromium (CoCr) everolimus-eluting stents (EES).
Objectives: The aim of this study was to evaluate the 5-year clinical outcomes of the novel sirolimus-eluting NeoVas BRS compared with CoCr EES.
Methods: A total of 560 patients with single de novo native coronary artery lesions with reference vessel diameter 2.
Age-Stratified Outcomes of Transvenous Lead Extraction: A 5,090-Patient Experience from the ExTRACT Registry.
Heart Rhythm
September 2025
Cardiac Electrophysiology Section, Department of Cardiovascular Medicine, Cleveland Clinic, Cleveland, Ohio. Electronic address:
Background: Transvenous lead extraction (TLE) is increasingly performed in older adults, but literature has reported divergent outcomes in very old populations.
Objective: To investigate the impact of patient age on TLE outcomes, with an emphasis on older patients.
Methods: Using the ExTRACT registry, the largest TLE registry to date, we analyzed 5,090 patients who underwent TLE between August 1996-2022 at the Cleveland Clinic, a high-volume center.
Active and Passive Cardiac Index as Complementary Predictors of Outcomes After LVAD Implantation.
J Thorac Cardiovasc Surg
September 2025
Department of Cardiovascular Surgery, Mayo Clinic, Rochester, Minnesota. Electronic address:
Introduction: Goals of left ventricular assist device (LVAD) therapy includes low rates of right ventricular failure (RVF) and favorable survival outcomes. However, conventional metrics often fail to capture its physiologic complexity. We evaluated the prognostic utility of the Active Cardiac Index (ActCI) and Passive Cardiac Index (PasCI)-which reflect cardiac output driven by active RV contractility and passive venous return, respectively.
View Article and Find Full Text PDF